Go back

Drugs industry calls for streamlined EU regulation


Call comes ahead of planned EU pharmaceutical strategy

Representatives of European drug companies have called on the EU to streamline its regulation of the sector, ahead of the European Commission’s much-anticipated proposal for a pharmaceutical strategy in the coming weeks.

“EU-level legislation should aim to simplify and streamline processes” around drug development and approval, authors including a regulatory strategy director at the European Federation of Pharmaceutical Industries and Associations wrote in a blog post published by Efpia on 23 February.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.